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Abstract
Introduction: Primary malignant melanoma of the esophagus is a rare but highly aggressive tumor
with poor prognosis. Surgical resection is the treatment of choice. However, some cases may be
diagnosed with advanced inoperable disease. Palliative radiotherapy may be used to relieve symptoms
caused by the esophageal tumor.
Case presentation: We report on a case of advanced inoperable primary malignant melanoma of the
esophagus treated with palliative radiotherapy. The patient’s dysphagia resolved with radiotherapy.
Conclusion: Malignant melanoma of the esophagus is rare. Patients with advanced inoperable
malignant melanomas of the esophagus benefit from radiation therapy. Radiation therapy is effective
for palliation.
Introduction
Primary malignant melanoma of the esophagus is an
uncommon disease accounting for only 0.1 % to 0.5 % of
all esophageal carcinomas [1-3]. It has a highly aggressive
tumor behavior with a median survival of about 10months
[4]. Some patients are inoperable at presentation. Radiation
therapy has been used to relieve symptoms. Malignant
melanomas are generally considered radioresistant,
requiring higher dose per fraction. We report on a case of
primary malignant melanoma of the esophagus treated
with palliative radiotherapy.
Case presentation
A 71-year-old male subject presented to us in very poor
general condition (Eastern Cooperative Oncology Group
performance status 3) with a history of hoarseness
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(3 months) and dysphagia (1 month). Clinically, the left
supraclavicular lymph node (3 × 3 cms) was palpable.
Computed tomography (CT) scan of the chest and
abdomen demonstrated extensive swelling of the med-
iastinal lymph nodes extending from 4 cm above the
level of the upper margin of the sternum to 2 cm below
the carina, the esophagus was compressed and trachea
shifted to the right of the midline. Primary esophageal
tumor was not separately identifiable from the mediast-
inal lymph nodes. Lymph nodes in the superior and
middle mediastinum measured approximately 12 × 7.7 ×
6.0 cm (Figure 1A). Left supraclavicular (3.3 × 3.0 cm)
and abdominal node (1.9 × 1.5 cm) metastases were also
observed (Figure 1B, 1C). Esophagoscopy demonstrated a
10 mm pigmented polypoidal lesion (25 cm from the
inscisor) and multiple pigmented flat lesions (Figure 2).
Esophageal narrowing due to extrinsic compression was
seen from 19 cm to 24 cm. Histopathology of the biopsy
specimen from the esophagus showed diffuse prolifera-
tion of atypical polygonal cells with hyperchromatic oval
to round nuclei, eosinophilic cytoplasm, and prominent
nucleoli, accompanied by various amounts of melanin
pigments and immunohistochemically - positive for S-100
protein. These findings were all compatible with malig-
nant melanoma of the esophagus. A final diagnosis
malignant melanoma of the esophagus T4N1M1a, stage
IVa (UICC-TNM classification [5]) was made.
Due to the fact that PS was 3, palliative radiotherapy
was offered for palliation of dysphagia and tracheal
compression and chemotherapy was not administrated.
He received radiation therapy for primary tumor and
mediastinal and left supraclavicular lymph nodes in a dose
of 45 Gy (gray) in 15 fractions over 3weeks at 5 fractions
per week, using anteroposterior and posteroanterior field
with10-MV photon. Patient tolerated the radiotherapy
well. The patient’s dysphagia resolved completely shortly
after radiotherapy. 1 week after radiotherapy there was a
marked decrease in the size of the mediastinal lymph
nodes and subject improved symptomatically. The axial
dimensions of the lymph node were maximal around the
level of the aortic arch where it measured approximately
4.5 × 3.5 cm 1week following completion of radiotherapy
(Figure 3). Patient had sustained palliation i.e, continuous
relief of dysphagia for 4 months after radiotherapy.
Discussion
Primary malignant melanoma affecting the esophagus is
a rare and fatal disease with a poor prognosis. Sabanathan
et al. documented that approximately 50% of patients
have metastatic disease at presentation and long-term
survival is extremely rare [6]. The clinical presentation of
primary malignant melanoma of the esophagus is similar
to the common forms of primary esophageal malignan-
cies. The tumor most commonly occurs in the 6th and 7th
decade, and the male to female ratio is 2:1. Subtotal
esophagectomy is recommended as the treatment of first
choice for primary malignant melanoma of the esophagus.
Sabanathan et al. reported a median survival of between
7 and 12 months in patients who underwent radical
Figure 1. Contrast enhanced CT showed 7.7 cms mediastinal
lymph nodes compressing the esophagus and trachea at the
level of the aortic arch (A), 3.3 × 3.0 cms left supraclavicular
(B) and 1.9 × 1.5 cms abdominal lymph nodes (C).
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resection and a 5 year survival of 4.2 % [7]. Chalkiadakis
et al. reported, in a series of 110 patients, a mean survival
of 13 months [8]. However, at the time of diagnosis, some
cases may be diagnosed as having inoperable carcinoma.
Chemotherapy is one of the treatment options for
malignant melanoma. However, it is difficult to use
chemotherapy to elderly or poor performance status
patients. Paul et al. reported that the response rate for
dacarbazine alone was 16.9 % and was 21.5% for
dacarbazine plus immunotherapy [9]. Although radio-
therapymay have a palliative role if surgery is not possible,
malignant melanoma has been considered radioresistant
[10]. At the time of diagnosis of the present case, multiple
lymph node metastases were observed and the perfor-
mance status was 3. Therefore, radical surgery and
chemotherapy were not considered. There have been
several case reports of effective palliation with photon
radiotherapy [11,12]. Forgarty et al. reported that a patient
with malignant melanoma of the esophagus received
36 Gy with a photon beam in six fractions given twice
weekly, and CT after 4 months following completion of
radiotherapy showed no residual mass [11]. In the present
case, palliative radiotherapy using a once-daily fractiona-
tion of 3.0 Gy was offered, and the tumor markedly
decreased in size and partial response was achieved.
Conclusion
Malignant melanoma of the esophagus is rare. Patients
with advanced inoperable melanomas of the esophagus
benefit from radiation therapy. Radiation therapy is
effective for palliation.
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